Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples